Search research articles
Contact Us
Filters
Showing results (31-40 of 69) with videos related to
Page
of 7
Sort By:
Annals of Hematology
|
October 6, 2010
Costs of managing severe immune thrombocytopenia in adults: a retrospective analysis
Mehdi Khellaf, Jean-Gabriel Le Moine, Priscille Poitrinal, et al.
Medicine
|
December 1, 2016
Long-term complications of splenectomy in adult immune thrombocytopenia
Lan-Huong Thai, Matthieu Mahévas, Françoise Roudot-Thoraval, et al.
Transfusion
|
September 26, 2009
Partial C antigen in sickle cell disease patients: clinical relevance and prevention of alloimmunization
Christophe Tournamille, Natacha Meunier-Costes, Bruno Costes, et al.
Stem Cell Research & Therapy
|
April 19, 2015
Development of a simple procedure for the treatment of femoral head osteonecrosis with intra-osseous injection of bone marrow mesenchymal stromal cells: study of their biodistribution in the early time points after injection
Angélique Lebouvier, Alexandre Poignard, Madeleine Cavet, et al.
Transfusion
|
May 1, 2018
High immunogenicity of red blood cell antigens restricted to the population of African descent in a cohort of sickle cell disease patients
Aline Floch, Dominique Gien, Christophe Tournamille, et al.
The Journal of Rheumatology
|
February 5, 2002
Treatment of severe immune thrombocytopenia associated with systemic lupus erythematosus: 59 cases
Christophe Arnal, Jean-charles Piette, Jean Léone, et al.
Annals of Hematology
|
August 6, 2013
Antiplatelet antibodies detected by the MAIPA assay in newly diagnosed immune thrombocytopenia are associated with chronic outcome and higher risk of bleeding
David Grimaldi, Florence Canouï-Poitrine, Laure Croisille, et al.
Stem Cell Research
|
October 23, 2015
Autologous bone marrow stromal cells are promising candidates for cell therapy approaches to treat bone degeneration in sickle cell disease
Angélique Lebouvier, Alexandre Poignard, Laura Coquelin-Salsac, et al.
Transfusion
|
May 18, 2016
Evidence of benefits from using fresh and cryopreserved blood to transfuse patients with acute sickle cell disease
Philippe Chadebech, Marie-Amélie de Ménorval, Gwellaouen Bodivit, et al.
Transfusion
|
August 30, 2007
Weak D phenotypes and transfusion safety: where do we stand in daily practice?
France Noizat-Pirenne, Martine Verdier, Annette Lejealle, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 69) with videos related to
Sort By:
Page
of 7
Annals of Hematology
|
October 6, 2010
Costs of managing severe immune thrombocytopenia in adults: a retrospective analysis
Mehdi Khellaf, Jean-Gabriel Le Moine, Priscille Poitrinal, et al.
Medicine
|
December 1, 2016
Long-term complications of splenectomy in adult immune thrombocytopenia
Lan-Huong Thai, Matthieu Mahévas, Françoise Roudot-Thoraval, et al.
Transfusion
|
September 26, 2009
Partial C antigen in sickle cell disease patients: clinical relevance and prevention of alloimmunization
Christophe Tournamille, Natacha Meunier-Costes, Bruno Costes, et al.
Stem Cell Research & Therapy
|
April 19, 2015
Development of a simple procedure for the treatment of femoral head osteonecrosis with intra-osseous injection of bone marrow mesenchymal stromal cells: study of their biodistribution in the early time points after injection
Angélique Lebouvier, Alexandre Poignard, Madeleine Cavet, et al.
Transfusion
|
May 1, 2018
High immunogenicity of red blood cell antigens restricted to the population of African descent in a cohort of sickle cell disease patients
Aline Floch, Dominique Gien, Christophe Tournamille, et al.
The Journal of Rheumatology
|
February 5, 2002
Treatment of severe immune thrombocytopenia associated with systemic lupus erythematosus: 59 cases
Christophe Arnal, Jean-charles Piette, Jean Léone, et al.
Annals of Hematology
|
August 6, 2013
Antiplatelet antibodies detected by the MAIPA assay in newly diagnosed immune thrombocytopenia are associated with chronic outcome and higher risk of bleeding
David Grimaldi, Florence Canouï-Poitrine, Laure Croisille, et al.
Stem Cell Research
|
October 23, 2015
Autologous bone marrow stromal cells are promising candidates for cell therapy approaches to treat bone degeneration in sickle cell disease
Angélique Lebouvier, Alexandre Poignard, Laura Coquelin-Salsac, et al.
Transfusion
|
May 18, 2016
Evidence of benefits from using fresh and cryopreserved blood to transfuse patients with acute sickle cell disease
Philippe Chadebech, Marie-Amélie de Ménorval, Gwellaouen Bodivit, et al.
Transfusion
|
August 30, 2007
Weak D phenotypes and transfusion safety: where do we stand in daily practice?
France Noizat-Pirenne, Martine Verdier, Annette Lejealle, et al.
Page
of 7